Stoke Therapeutics, Inc. Common Stock (STOK) News
Latest headlines that mention STOK, newest first · each headline opens the original publisher
- Last price
- $27.74
- Day change
- +4.52%
- Next earnings
- —
STOK headlines
last 30 daysDravet syndrome trial enrollment exceeded targets with zero discontinuations.
STOK news alerts
Get an alert by email or push when a new headline mentions STOK.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.